Social Media Content Creators Driving Parallel Trade for Unlicensed Slimming Drug
An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Drug Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these profiles directly for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and chemists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could lead to individuals administering products of unknown origin.
Several experts stated the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Platform Reaction and Content Elimination
According to TikTok, the platform has taken down problematic content and prohibited related keywords and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Research also discovered groups with up to nine thousand members marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, filled with images of slimming results, glowing reviews and step-by-step guides for mixing or administering at home.
After minutes of entering one group, a vendor shared contact information, where the majority of transactions occur. The seller provided an guidebook and promised shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Item Information and Costs
Inside these groups, posts show dark colored parcels with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When asked how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram stated it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they cannot confirm. Although the science behind retatrutide is valid, these online versions may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has previously seen individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may expose patients to possibly serious medical dangers”.